Related Experiment Videos
Essential blepharospasm and related dystonias
D R Jordan1, J R Patrinely, R L Anderson
1Department of Ophthalmology, University of Utah School of Medicine, Salt Lake City.
Survey of Ophthalmology
|September 1, 1989
Summary
Essential blepharospasm involves involuntary facial muscle spasms. Botulinum-A toxin offers temporary relief, while periorbital myectomy provides the best long-term results for this debilitating condition.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Essential blepharospasm is an idiopathic neurological disorder characterized by progressive, involuntary spasms of facial muscles, primarily the orbicularis oculi.
- The condition often extends to involve lower facial and neck muscles, manifesting as Meige's syndrome or orofacial dystonia.
- Severe spasms can lead to functional impairment and cosmetic deformities of the eyelids.
Purpose of the Study:
- To review the efficacy of various treatment modalities for essential blepharospasm.
- To compare the short-term and long-term outcomes of different therapeutic interventions.
Main Methods:
- Review of existing literature on essential blepharospasm treatments.
- Analysis of reported outcomes for oral medications, botulinum-A toxin injections, and surgical interventions like periorbital myectomy.
Main Results:
- Oral medications and other modalities demonstrate limited efficacy in managing essential blepharospasm.
- Botulinum-A toxin injections provide significant temporary relief for patients.
- Periorbital myectomy surgery has shown the most favorable long-term results in alleviating symptoms.
Conclusions:
- Essential blepharospasm is a challenging condition with limited treatment options.
- Botulinum-A toxin is effective for temporary symptom management.
- Periorbital myectomy represents the optimal surgical approach for sustained relief from essential blepharospasm.